It provides information on the test gene, and provides detailed information to the log-in user.
| No. | Ingredient name | Drug classification | Main diseases | Genetic biomarkers |
|---|---|---|---|---|
| 191 | Irbesartan |
Antihypertensive agents | Essential hypertension, renal disease in patients with type 2 diabetes mellitus with hypertension | CYP2C9 , ACE |
| 192 | Enalapril |
Antihypertensive agents | Hypertension, heart failure | ACE , SLCO1B1 |
| 193 | Atorvastatin |
Antiarteriosclerotic agents | Cardiovascular disease, primary hypercholesterolemia, heterozygous familial hypercholesterolemia | SLCO1B1 , COQ2 |
| 194 | Simvastatin |
Antiarteriosclerotic agents | Hyperlipidemia, pediatric patients with heterozygous familial hypercholesterolemia | SLCO1B1 |
| 195 | Cerivastatin |
Antiarteriosclerotic agents | Hyperlipidemia, pediatric patients with heterozygous familial hypercholesterolemia | SLCO1B1 |
| 196 | Metoprolol |
Antihypertensive agents | Hypertension | CYP2D6 |
| 197 | Lisinopril |
Antihypertensive agents | Hypertension, congestive heart failure, kidney complications in diabetic patients | ACE , MMP3 |
| 198 | Rosuvastatin |
Antiarteriosclerotic agents | Primary hypercholesterolemia, complexity hyperlipidemia, primary fredrickson type IIb hyperlipidemia, familial hypercholesterolemia homozygote | SLCO1B1 , ABCG2 , COQ2 |
| 199 | Losartan |
Antihypertensive agents | Hypertension, kidney disease in hypertensive patients with type 2 diabetes | CYP2C9 , AGTR1 |
| 200 | Nifedipine |
Vasodilators | Coronary heart disease (chronic stable angina), hypertension | ADRA1A , SLC14A2 |
Drag left and right